Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 5/20 | 0.44 |
| ▸ | AKT2 | P31751 | 5/20 | 0.44 |
| ▸ | AKT3 | Q9Y243 | 5/20 | 0.44 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.44 |
| ▸ | CETP | P11597 | 1/20 | 0.43 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.43 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.43 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.41 |
| ▸ | PRKCG | P05129 | 1/20 | 0.41 |
| ▸ | PRKCB | P05771 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | PRKCH | P24723 | 1/20 | 0.41 |
| ▸ | PRKCI | P41743 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23000963 | 0.91 | CETP (0.53) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL17188245 | 0.91 | CETP (0.53) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL14666330 | 0.91 | CETP (0.53) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL19079075 | 0.91 | CETP (0.53) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL17817032 | 0.91 | CETP (0.53) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL19079096 | 0.90 | GJB2 (0.43) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL19079148 | 0.90 | GJB2 (0.43) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL7167831 | 0.87 | CETP (0.45) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL19079084 | 0.87 | CETP (0.45) | MAPK1AKT1AKT2AKT3PIK3R1 | |
| SCHEMBL17817172 | 0.87 | CETP (0.45) | MAPK1AKT1AKT2AKT3PIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130029925-A1 | Method for Preventing Cancer Metastasis | UNIVERSITE DE BRETAGNE OCCIDENTALE (U.B.O.) (FR) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029925-A1 | Method for Preventing Cancer Metastasis | SGMS2, SGMS1, LPCAT3 | MAPK1 3089/4885AKT1 2463/4885AKT2 1674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.